Languages
Pages
Legal
Explore all categories to find your favorite topic
1. DR. JUAN CARLOS BECERRA MARTINEZ ADIESTRAMIENTO EN HEMODINÁMICA UMAE HE CMNO, GUADALAJARA, MÉXICO STENTS LIBERADORES DE FÁRMACOS 2. N Engl J Med 2013; 368:254-265 3.…
PowerPoint Presentation Drug Eluting Coronary Stent Coatings Part 10: Drug Eluting Heart Stent Coatings 1 Copyright ©1996 American Heart Association Edelman, E. R. et al.…
1. Issue date: July 2008Review date: April 2009Drug-eluting stents for thetreatment of coronary arterydisease Part review of NICEtechnology appraisal guidance 71NICE technology…
DRAFT Contains Nonbinding Recommendations Draft â Not for Implementation 6255companion.doc 4/7/2008 Guidance for Industry Coronary Drug-Eluting Stents â Nonclinical and…
TITLE: Bioabsorbable Stents for Adults with Coronary Artery Disease: A Review of the Clinical Effectiveness Cost-Effectiveness and Guidelines DATE: 10 December 2013 CONTEXT…
Safety of Drug-Eluting Stents in Acute Coronary Syndromes Rotterdam, June 11th 2012 Stephan Windecker Department of Cardiology Swiss Cardiovascular Center and Clinical Trials…
c AZOTH Analytics November 2016 Global Coronary Stents Market Bare Metal Drug-Eluting Bioresorable: Analysis By Segment By Region By Country 2016-2021 • By Segment - Bare…
EVEROLIMUS ELUTING CORONARY STENTS FOR LONG INFRA-POPLITEAL LESIONS FOR CRITICAL LIMB ISCHEMIA: LONG DES-BTK Robert Lookstein MD MHCDL FSIR FAHA FSVM Professor of Radiology…
Slide 1Prospective, Randomized Trial of Paclitaxel- versus Sirolimus- Eluting Stents for Treatment of Coronary Restenosis in Sirolimus-Eluting Stents Robert A. Byrne, Julinda…
Company Profiling November 2016 Global Coronary Stents Market (Bare Metal, Drug-Eluting, Bioresorable): Analysis By Segment, By Region, By Country (2016-2021) By Segment…
Drug-eluting stents for the treatment of coronary artery disease (NICE technology appraisal guidance 152)NICE technology appraisal guidance 152 Drug-eluting stents for the
Hindawi Publishing Corporation ISRN Cardiology Volume 2013 Article ID 748736 8 pages http:dxdoiorg1011552013748736 Review Article Risk Factors for Coronary Drug-Eluting Stent…
Off-label use of coronary drug-eluting stents Occurrence safety and effectiveness in ‘real world’ clinical practice RIVM report 3600500242011 B Roszek R de Water JWGA…
review article T h e n e w e ngl a nd j o u r na l o f m e dic i n e n engl j med 3683 nejm.org january 17, 2013254 Drug Therapy Drug-Eluting Coronary-Artery Stents Giulio…
Prior Authorization Review Panel MCO Policy Submission A separate copy of this form must accompany each policy submitted for review Policies submitted without this form will…
Journal Papers 1-44 1. Mäkikallio, Timo et al., Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis NOBLE:…
P M J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S V O L 4 N O 6 2 0 1 1 © 2 0 1 1 B Y T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y F O U…
Biomaterials Research 2010 141 : 37-49 37 Biomaterials Research C The Korean Society for Biomaterials 약물방출 스텐트Drug-Eluting Stents 개발의 최신 동향 An…
SORT-OUT III: A Prospective Randomized Comparison of Zotarolimus-Eluting and Sirolimus-Eluting Stents in Patients with Coronary Artery Disease Michael Maeng, Klaus Rasmussen,…
* Endothelial injury post implantation Stent implantation causes arterial injury, which can initiate restenosis. The restenosis process includes inflammation, migration of…